Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Hohnloser

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
Current Opinion in Cardiology|January 1, 1997
Drug treatment of atrial fibrillation: what have we learned?S H Hohnloser, Y G Li
Journal of Cardiovascular Electrophysiology|October 1, 1995
Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implicationsS H Hohnloser, B N Singh
The American Journal of Cardiology|November 21, 2000
Current status of dual-sensor pacemaker systems for correction of chronotropic incompetenceC W Israel, S H Hohnloser
Hamostaseologie|June 29, 2012
Dabigatran for stroke prevention in atrial fibrillationS H Hohnloser, H-C Diener
Deutsche Medizinische Wochenschrift (1946)|April 20, 1990
[Proarrhythmic effects of anti-arrhythmia agents]S H Hohnloser, P J Podrid
Journal of Cardiovascular Electrophysiology|September 4, 1998
Atrial fibrillation--maintaining sinus rhythm versus ventricular rate control: the PIAF trial. Pharmacological Intervention in Atrial FibrillationS H Hohnloser, K H Kuck
Pacing and Clinical Electrophysiology : PACE|August 1, 1997
Atrial fibrillation: maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: the PIAF trialS H Hohnloser, K H Kuck
Journal of Cardiovascular Electrophysiology|May 1, 1995
Circadian variation of heart rate variability in postinfarction patients with and without life-threatening ventricular tachyarrhythmiasT Klingenheben, U Rapp, S H Hohnloser
Zeitschrift Fur Kardiologie|April 29, 1998
[Brief analysis of heart rate variability in for determining prognosis in the post-myocardial infarct period: methodologically reliable alternative to long-term ECG?]T Klingenheben, M Zabel, S H Hohnloser
Zeitschrift Fur Kardiologie|January 1, 1992
[Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study]T Meinertz, M Zehender, S H Hohnloser
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
Current Opinion in Cardiology|January 1, 1997
Drug treatment of atrial fibrillation: what have we learned?S H Hohnloser, Y G Li
Journal of Cardiovascular Electrophysiology|October 1, 1995
Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implicationsS H Hohnloser, B N Singh
The American Journal of Cardiology|November 21, 2000
Current status of dual-sensor pacemaker systems for correction of chronotropic incompetenceC W Israel, S H Hohnloser
Hamostaseologie|June 29, 2012
Dabigatran for stroke prevention in atrial fibrillationS H Hohnloser, H-C Diener
Deutsche Medizinische Wochenschrift (1946)|April 20, 1990
[Proarrhythmic effects of anti-arrhythmia agents]S H Hohnloser, P J Podrid
Journal of Cardiovascular Electrophysiology|September 4, 1998
Atrial fibrillation--maintaining sinus rhythm versus ventricular rate control: the PIAF trial. Pharmacological Intervention in Atrial FibrillationS H Hohnloser, K H Kuck
Pacing and Clinical Electrophysiology : PACE|August 1, 1997
Atrial fibrillation: maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: the PIAF trialS H Hohnloser, K H Kuck
Journal of Cardiovascular Electrophysiology|May 1, 1995
Circadian variation of heart rate variability in postinfarction patients with and without life-threatening ventricular tachyarrhythmiasT Klingenheben, U Rapp, S H Hohnloser
Zeitschrift Fur Kardiologie|April 29, 1998
[Brief analysis of heart rate variability in for determining prognosis in the post-myocardial infarct period: methodologically reliable alternative to long-term ECG?]T Klingenheben, M Zabel, S H Hohnloser
Zeitschrift Fur Kardiologie|January 1, 1992
[Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study]T Meinertz, M Zehender, S H Hohnloser
Pageof 16